Clinical Impact of Liraglutide as a Treatment of Obesity
Clinical Pharmacology: Advances and Applications · 2021-03 · Volume 13 · 53-60
DOI: 10.2147/cpaa.s276085 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Pharmacology: Advances and Applications, 2021-03. Verfasst von Heshma Alruwaili und 2 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Complications Research Centre, Conway Institute, University College Dublin, Dublin, Ireland. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Diabetes Complications Research Centre, Conway Institute, University College Dublin, Dublin, Ireland.
- Diabetes Research Group, School of Biomedical Sciences, Ulster University, Belfast, UK.
ORCID-Profile: Heshma Alruwaili
Zitieren
APA
Alruwaili, H., Dehestani, B., & le Roux, C. W. (2021). Clinical Impact of Liraglutide as a Treatment of Obesity. Clinical Pharmacology: Advances and Applications, Volume 13, 53-60. https://doi.org/10.2147/cpaa.s276085
Vancouver
Alruwaili H, Dehestani B, le Roux CW. Clinical Impact of Liraglutide as a Treatment of Obesity. Clinical Pharmacology: Advances and Applications. 2021;Volume 13:53-60. doi:10.2147/cpaa.s276085
BibTeX
@article{Alruwaili2021,
author = {Alruwaili, Heshma and Dehestani, Babak and le Roux, Carel W},
title = {Clinical Impact of Liraglutide as a Treatment of Obesity},
journal = {Clinical Pharmacology: Advances and Applications},
year = {2021},
volume = {Volume 13},
pages = {53--60},
doi = {10.2147/cpaa.s276085}
}
EUVIMED